Sepsis ImmunoScore vs Viz CTP
AI Verdict
Choose Sepsis ImmunoScore if…
Choose Sepsis ImmunoScore if your primary need is rapid, AI-driven risk assessment and prediction of adverse outcomes specifically for sepsis patients. This tool excels at leveraging existing EHR data to provide a transparent risk score and categories, guiding faster treatment decisions and improving patient outcomes within 24 hours.
View Sepsis ImmunoScore →Choose Viz CTP if…
Choose Viz CTP if your focus is on accelerating the detection and treatment of various conditions through AI-powered medical imaging analysis and intelligent care coordination. This platform is ideal for scenarios requiring real-time mobile access to high-fidelity imaging, automated interpretation, and streamlined communication among care teams to expedite critical interventions.
View Viz CTP →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Sepsis ImmunoScore | Viz CTP |
|---|---|---|
| Pricing | Enterprise subscription model | Subscription model |
| Deployment | Integrated into hospital EHR/EMR systems | Cloud-native solution, integrates with PACS and EHRs. |
| FDA Status | 1 AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Viz CTPViz CTP offers real-time, mobile access to high-fidelity imaging with 3D manipulation and a HIPAA-compliant communication platform, providing a highly flexible and integrated user experience for care coordination. Sepsis ImmunoScore focuses on an intuitive display within the EHR that explains score contributions, which is valuable for transparency but less expansive in terms of workflow and access features.
Clinical Value
Viz CTPViz CTP boasts over 50 FDA-cleared algorithms for AI-powered disease detection and automated image analysis across various conditions, indicating a broad and validated clinical impact. While Sepsis ImmunoScore is a significant 'first' for sepsis diagnosis and prediction, Viz CTP's extensive portfolio suggests a wider range of clinical applications and benefits across multiple disease states.
Pricing & Value
TieBoth tools operate on an enterprise subscription model with pricing that varies based on client needs and scale, and neither publicly discloses specific pricing details. While Viz CTP's model is based on the number of algorithms and population served, and Viz.ai offers an aneurysm calculator to estimate economic impact, there isn't enough transparent information to definitively declare one offers superior value or pricing transparency over the other.
Enterprise Readiness
Viz CTPViz CTP is a cloud-native solution that integrates with PACS and EHRs, and its extensive suite of over 50 FDA-cleared algorithms demonstrates a robust, scalable platform capable of supporting diverse enterprise-level imaging and clinical workflows. Sepsis ImmunoScore is also enterprise-ready with EHR integration and FDA authorization, but its singular focus on sepsis makes Viz CTP's broader platform more indicative of comprehensive enterprise readiness.
Innovation
Sepsis ImmunoScoreSepsis ImmunoScore stands out as the 'first FDA-authorized AI diagnostic for sepsis,' representing a landmark innovation in a critical and challenging diagnostic area. While Viz CTP is a pioneer with numerous FDA-cleared algorithms and advanced imaging features, Sepsis ImmunoScore's specific 'first' for sepsis is a singular, high-impact breakthrough.
Support & Docs
Viz CTPViz CTP offers comprehensive support, including a knowledge base, help center with tutorials and troubleshooting, and 24/7/365 urgent phone support, along with email support and a 'Viz Academy' for training. Sepsis ImmunoScore mentions training availability and billing guides, but does not detail the same breadth of readily accessible and continuous support channels.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Sepsis ImmunoScore | Viz CTP |
|---|---|---|
| Name | Sepsis ImmunoScore | Viz CTP |
| Company | Prenosis | Viz.ai |
| Description | First FDA-authorized AI diagnostic for sepsis, providing rapid risk assessment and prediction of adverse outcomes. It analyzes 22 parameters from EHRs to generate a risk score and four risk categories, aiding clinicians in faster treatment decisions and improved patient outcomes. | AI-powered disease detection and intelligent care coordination, leveraging over 50 FDA-cleared algorithms to analyze medical imaging and streamline clinical workflows for faster diagnosis and treatment. |
| Key Functionality | Guides rapid diagnosis and prediction of sepsis, leverages 22 diverse parameters, outputs a risk score and four discrete risk categories, predicts risk of deterioration within 24 hours | AI-powered disease detection, real-time mobile access to high-fidelity imaging, intelligent care coordination and communication platform, automated image analysis and interpretation (e.g., CT perfusion maps, LVO detection) |
| Specialties | Critical Care, Emergency Medicine, Hospital Medicine | Emergency Medicine, Neurology, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Sepsis ImmunoScore and Viz CTP.
Frequently Asked Questions
More Comparisons
More matchups featuring Sepsis ImmunoScore or Viz CTP
Backers
Who funded each tool's parent company.